Latest news

How can researchers have successful collaborations with industry in clinical studies? This was a central question at a recent CONNECT semina

How can clinicians be more involved in healthcare decision-making?

Industry-sponsored clinical studies in Norway were in focus at the kick-off meeting for a new meeting series hosted by CONNECT Working Group

The first national initiatives for precision cancer medicine have successfully taken shape in Norway, but what has been achieved and what do

CONNECT welcomes the two new partners Gilead Sciences Nordic Region and the Norwegian Directorate for E-health.

Experts from regional, national and international groups shared their perspectives on digital pathology and artificial intelligence (AI)...

Norway is pioneering precision medicine in cancer with three nation-wide initiatives.

Nukleærmedisin med presisjonsdiagnostikk og persontilpasset behandling. Nukleærmedisin omfatter både diagnostikk og behandling ved bruk...

CONNECT’s newest partner, GSK, sponsors the Cancer Crosslinks 2022, and is increasing its focus on oncology and hematology. These are...